Huadong Medicine
Pharmaceutical and aesthetics company developing and commercializing metabolic, oncology and immunology products.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Obesity Control
Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesPhase 3 · Recruiting · Obesity & Overweight
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusPhase 3 · Recruiting · Type 2 Diabetes
A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusPhase 3 · Recruiting · Type 2 Diabetes
A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AlonePhase 3 · Recruiting · Type 2 Diabetes
A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy SubjectsPhase 1 · Recruiting · Healthy Adult Subject
Selected patent records
liraglutide · Expires 2025-08-13
US 8114833*PEDliraglutide · Expires 2026-02-13
US 9968659liraglutide · Expires 2037-01-09
US 9968659*PEDliraglutide · Expires 2037-07-09
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/huadong-medicine/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.